STOCK TITAN

MicroVision director adds 4,670 shares in RSU vest

MicroVision director Robert Paul Carlile reported 4,670 RSUs vesting into common stock, bringing his direct holdings to 42,051 shares without using a Rule 10b5-1 plan.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MICROVISION, INC. (MVIS) director Robert Paul Carlile reported the vesting and settlement of restricted stock units into common stock. On September 1, 2026, 4,670 RSUs were converted on a unit-for-share basis into 4,670 shares of common stock at no cash cost, increasing his directly held common shares to 42,051. The corresponding RSU derivative position was reduced to zero. No Rule 10b5-1 trading plan is reported.

Footnotes state these RSUs are part of a grant made on July 16, 2026 that is scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision’s 2027 Annual Meeting of Stockholders, with the original grant of 280,152 RSUs on a pre-split basis equating to 18,677 RSUs on a post-split basis.

Positive

  • None.

Negative

  • None.
Insider Carlile Robert Paul
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F2, F3 4,670 $0.00 $0.00
Exercise Common Stock F1 4,670 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 42,051 shares (Direct)
Footnotes (3)
  1. F1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
  2. F2. At vesting, converts into shares of common stock on a unit-for-share basis.
  3. F3. RSUs granted 07/16/2026 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 07/17/2026 reports 280,152 RSUs granted on a pre-split basis, which equates to 18,677 on a post-split basis.
RSUs converted to common stock 4,670 units/shares Restricted stock units vested and distributed on September 1, 2026
Common stock holdings after transaction 42,051 shares Directly held by Robert Paul Carlile following the September 1, 2026 settlement
Original RSU grant (pre-split basis) 280,152 RSUs Grant reported as of July 16, 2026 on a pre-split basis
Equivalent RSU grant (post-split basis) 18,677 RSUs 280,152 pre-split RSUs equate to 18,677 RSUs on a post-split basis
Vesting installments 4 equal quarterly installments RSUs vest until fully vested by first anniversary of grant or day before 2027 Annual Meeting
Restricted Stock Units financial
"Vested restricted stock units, or RSUs, were distributed to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
unit-for-share basis financial
"distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis"
pre-split basis financial
"reports 280,152 RSUs granted on a pre-split basis, which equates to 18,677"
post-split basis financial
"280,152 RSUs granted on a pre-split basis, which equates to 18,677 on a post-split basis"
Annual Meeting of Stockholders regulatory
"the day prior to the Issuer's 2027 Annual Meeting of Stockholders"

FAQ

What insider transaction did MicroVision (MVIS) director Robert Paul Carlile report?

Robert Paul Carlile reported the vesting and conversion of 4,670 restricted stock units into 4,670 shares of MicroVision common stock on September 1, 2026. The RSUs converted on a unit-for-share basis and did not involve a cash purchase price.

How many MicroVision (MVIS) shares does Robert Paul Carlile hold after this Form 4?

After the reported transaction, Robert Paul Carlile directly holds 42,051 shares of MicroVision common stock. This reflects the addition of 4,670 shares received from the vesting and settlement of restricted stock units on September 1, 2026.

What happened to the 4,670 restricted stock units reported for MicroVision (MVIS)?

The 4,670 restricted stock units vested and were distributed as 4,670 shares of common stock to Robert Paul Carlile on a unit-for-share basis. Following this conversion, the reported RSU derivative position associated with this grant is 0 units.

Was Robert Paul Carlile’s MicroVision (MVIS) transaction under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is associated with these transactions. The box affirming use of a Rule 10b5-1 plan is explicitly unchecked in the filing’s metadata.

What is the vesting schedule for Robert Paul Carlile’s RSU grant at MicroVision (MVIS)?

The RSUs granted on July 16, 2026 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to MicroVision’s 2027 Annual Meeting of Stockholders.

How large is Robert Paul Carlile’s RSU grant referenced in this MicroVision (MVIS) Form 4?

The filing notes that a grant of 280,152 RSUs on a pre-split basis equates to 18,677 RSUs on a post-split basis. These RSUs vest in four equal quarterly installments subject to continued service as a director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carlile Robert Paul

(Last)(First)(Middle)
18390 NE 68TH STREET

(Street)
REDMOND WASHINGTON 98052

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026M4,670A$0.00(1)42,051D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0.00(2)09/01/2026M4,67009/01/2026(3)09/01/2026(3)Common stock4,670$0.000D
Explanation of Responses:
1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
2. At vesting, converts into shares of common stock on a unit-for-share basis.
3. RSUs granted 07/16/2026 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 07/17/2026 reports 280,152 RSUs granted on a pre-split basis, which equates to 18,677 on a post-split basis.
/s/ Drew G. Markham, attorney-in-fact for Robert Paul Carlile09/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)